Format

Send to

Choose Destination
Immunity. 2004 Mar;20(3):243-4.

Unraveling the NALP-3/IL-1beta inflammasome: a big lesson from a small mutation.

Author information

1
University Colorado Health Sciences Center, Division of Infectious Diseases, B168, 4200 East Ninth Avenue, Denver, CO 80262, USA.

Abstract

Cytokine-mediated inflammation is a target for novel therapies as well as for fundamental research. A single amino acid mutation in the NALP-3 gene controlling the activation of caspase-1 results in increased processing of the inactive IL-1beta precursor and release of the active cytokine. Blocking IL-1 receptors arrests inflammation in humans with the mutation.

PMID:
15030767
DOI:
10.1016/s1074-7613(04)00055-x
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center